Macquarie Investment Management Adds to Insurance Distribution Efforts

Thomas Hobson joins the firm as associate director, insurance solutions

PHILADELPHIA--(BUSINESS WIRE)-- Macquarie Investment Management today announced that Thomas Hobson, CFA, has joined the firm as associate director, insurance solutions. Hobson is responsible for expanding the firm’s asset management relationships with insurers.

Hobson joins Macquarie from BlackRock Investment Management where he most recently served as relationship manager and head of business development for retail financial institutions. He reports to Brett Wright, co-head of client group, Macquarie Investment Management, Americas, and is based in Philadelphia.

“In today’s environment, insurers are seeking opportunities to find yield in a variety of asset classes,” said Wright. “As a leader in the space, we are well-positioned to provide asset liability and risk management services and grow opportunities with insurers globally. We are delighted to have Tom on board and are confident he will be a valuable player as we expand our distribution efforts to support our insurance solutions.”

Prior to his tenure at BlackRock, Hobson was a director of product strategy for Nationwide Investment Management. He also held various roles at Morgan Stanley Investment Management and The Vanguard Group. Hobson is a chartered financial analyst and a graduate of The Pennsylvania State University.

About Macquarie Investment Management

Macquarie Investment Management is a global asset manager with offices throughout the US, Europe, Asia, and Australia. As active managers, we prioritize autonomy and accountability at the team level in pursuit of opportunities that matter for clients. Our conviction-based, long-term approach has led institutional and individual clients to entrust us to manage US$236.6 billion in assets as of March 31, 2017. Macquarie Investment Management is a division of Macquarie Asset Management, a global asset manager with US$367.2 billion in assets under management as of March 31, 2017.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170522006179/en/

Macquarie Investment Management
Daniela Palmieri, 215-255-8878
[email protected]
or
Jessica Fitzgerald, 215-255-1336
[email protected]

Source: Macquarie Investment Management

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Aura Q3 2026 Earnings Call and Quarterly Results
• Eikon Therapeutics Announces Availability of Seven Abstracts for Presentation at the European Society for Medical Oncology Congress
• Disc Medicine to Host Corporate Webcast to Discuss Topline Results from the APOLLO Phase 3 Trial of Bitopertin in Erythropoietic Protoporphyria (EPP)